Venus Remedies Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: VENUSREM BSE: 526953

₹1778.00

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #73 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Venus Remedies Limited (this stock)	2,377	21.0	15.5%	278.0%	0.56%	81	68	88

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹2,353 Cr

EV / EBITDA

13.5x

EV / Sales

2.90x

Market cap / Sales

2.93x

Earnings yield

4.76%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 181 Cr, up 29.7% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 26 Cr, up 118.4% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	179	33	26	₹19.1000
March 31, 2026	259	58	43	₹32.5100
Dec. 31, 2025	180	33	25	₹18.6400
Sept. 30, 2025	193	26	19	₹14.4000
June 30, 2025	132	15	12	₹8.7500
March 31, 2025	194	25	15	₹11.0700
Dec. 31, 2024	173	29	24	₹18.0200
Sept. 30, 2024	167	15	9	₹6.9200
June 30, 2024	106	10	4	₹3.3300
March 31, 2024	175	19	13	₹
Dec. 31, 2023	131	9	8	₹6.1300
Sept. 30, 2023	170	10	5	₹4.0700
June 30, 2023	99	8	4	₹3.2500

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	181	264	182	194	140	201	174	178	107	134	173	101	152
Operating revenue	179	259	180	193	132	194	173	167	106	131	170	99	149
Other income	3	5	2	2	8	7	2	11	2	2	3	2	3
Operating expenses	142	200	143	163	119	171	—	—	—	—	—	—	—
Operating profit	37	59	37	30	13	23	—	—	—	—	—	—	—
Operating profit margin	20.4%	22.9%	20.4%	15.5%	9.6%	11.6%	—	—	—	—	—	—	—
Depreciation	7	6	6	6	6	4	5	6	6	6	6	7	8
Interest	0	0	0	0	0	0	—	—	—	—	—	—	—
Exceptional items, gain / (loss)	—	—	—	—	—	—	10	—	—	—	—	—	—
Profit before tax	33	58	33	26	15	25	29	15	10	9	10	8	16
Tax	7	14	8	6	3	7	5	6	6	1	4	4	9
Net profit	26	43	25	19	12	—	24	9	4	8	5	4	8
EPS	19.10	32.51	18.64	14.40	8.75	11.07	18.02	6.92	3.33	6.13	4.07	3.25	5.64
Net profit (TTM)	113	99	—	—	—	—	46	27	22	26	20	22	29
EPS (TTM)	84.65	74.30	52.86	52.24	44.76	39.34	34.40	20.45	16.78	19.09	14.91	16.62	21.67

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	769	131	99
March 31, 2025	639	79	53
March 31, 2024	575	47	30
March 31, 2023	538	40	29

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	12.8%	8.1%	785^†	660^†	—	548^†	584^†	532^†	326^†	307^†	356^†	376^†
Operating revenue	12.7%	8.4%	769	639	575	538	575^†	515^†	322^†	302^†	355^†	375^†
Other income	—	—	17^†	21^†	—	10^†	8^†	18^†	4^†	6^†	1^†	1^†
Operating expenses	—	—	625^†	—	—	—	—	468^†	276^†	—	292^†	275^†
Operating profit	—	25.2%	144^†	—	—	—	—	47^†	47^†	—	63^†	101^†
Operating profit margin	—	—	18.7%^†	—	—	—	—	9.1%^†	14.5%^†	—	17.8%^†	26.8%^†
Depreciation	—	—	25^†	22^†	—	31^†	33^†	34^†	31^†	33^†	33^†	41^†
Interest	—	—	0^†	—	—	—	—	13^†	17^†	—	35^†	34^†
Exceptional items, gain / (loss)	—	—	0^†	10^†	—	0^†	0^†	23^†	-9^†	-9^†	0^†	0^†
Profit before tax	48.0%	26.1%	131	79	47	40	45^†	41^†	-6^†	-28^†	-4^†	1^†
Tax	—	—	31^†	24^†	—	11^†	-4^†	—	—	—	—	—
Net profit	50.8%	12.8%	99	53	30	29	49^†	54^†	-8^†	-27^†	-7^†	5^†
EPS	50.8%	11.1%	74.30^†	39.34^†	—	21.67^†	36.79^†	43.99^†	-6.67^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	18.7%^†	—	—	—	—	9.1%^†	14.5%^†	—	17.8%^†	26.8%^†
EBIT margin	17.0%^†	—	—	—	—	10.5%^†	3.3%^†	—	8.8%^†	9.2%^†
PBT margin	17.0%	12.4%	8.1%	7.5%	7.8%^†	8.0%^†	-1.9%^†	-9.4%^†	-1.1%^†	0.3%^†
Net margin	12.9%	8.2%	5.3%	5.4%	8.5%^†	10.5%^†	-2.6%^†	-9.0%^†	-2.0%^†	1.3%^†
Interest coverage	—	—	—	—	—	4.23x^†	0.63x^†	—	0.89x^†	1.03x^†
Dividend payout	0.0%^†	0.0%^†	—	0.0%^†	0.0%^†	0.0%^†	—	—	—	—
Earnings retention	100.0%^†	100.0%^†	—	100.0%^†	100.0%^†	100.0%^†	—	—	—	—
Current ratio	2.56x	4.14x	—	—	—	—	—	—	—	—
Quick ratio	1.75x	3.19x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—	—
Return on equity	14.4%	8.9%	—	—	—	—	—	—	—	—
Return on assets	11.3%	7.4%	—	—	—	—	—	—	—	—
Return on capital employed	18.2%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.88x	0.90x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	151	-182	-1	38	113
March 31, 2025	83	-76	0	10	74
March 31, 2024	35	-7	0	9	26
March 31, 2023	28	-51	0	8	20
March 31, 2022	41	-17	-9	14	27

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	876	690	676	0	0	406	158	24	110	129
March 31, 2025	713	590	576	0	0	436	105	55	111	100
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.